Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-04-24
2007-04-24
Romeo, David (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S387300, C530S388100, C530S389100, C530S389200, C530S866000
Reexamination Certificate
active
10123481
ABSTRACT:
The present invention relates to a novel FGF-13 protein which is a member of the fibroblast growth factor (FGF) family. In particular, isolated nucleic acid molecules are provided encoding the human FGF-13 protein. FGF-13 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of FGF-13 activity. Also provided are diagnostic methods for detecting FGF-13-related disorders and therapeutic methods for treating FGF-13-related disorders. Disclosed is a method of prolonging dopaminergic neuron survival.
REFERENCES:
patent: 5693775 (1997-12-01), Nathans et al.
patent: 5728546 (1998-03-01), Green et al.
patent: 5767073 (1998-06-01), Lim et al.
patent: 5773252 (1998-06-01), Green et al.
patent: 5783568 (1998-07-01), Schlessinger et al.
patent: 05-222096 (1993-08-01), None
patent: 264481 (1995-12-01), None
patent: WO-95/03831 (1995-02-01), None
patent: WO-95/14772 (1995-06-01), None
patent: WO-95/24928 (1995-09-01), None
patent: WO-96/39508 (1996-12-01), None
patent: WO-96/39509 (1996-12-01), None
patent: WO-97/44468 (1997-11-01), None
patent: WO-98/08864 (1998-03-01), None
patent: WO-98/16644 (1998-04-01), None
patent: WO-98/23749 (1998-06-01), None
patent: WO-99/14327 (1999-03-01), None
patent: WO-99/14328 (1999-03-01), None
Tanaka et al. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc Natl Acad Sci U S A. Oct. 1, 1992;89(19):8928-32.
Ataliotis, et al., “Distribution and functions of platelet-derived growth factors and their receptors during embryogenesis,” Int. Rev. Cytol., 172:95-127 (1997).
Crossley, et al., “Roles for FGF8 in the induction, initiation, and maintenance of chick limb development,” Cell 84(1):127-136 (1996).
Galzie, et al., “Fibroblast growth factors and their receptors,” Biochem. Cell Biol., 75(6):669-685 (1997).
Ghosh, et al., “Molecular cloning and characterization of human FGF8 alternative messenger RNA forms,” Cell Growth & Differ., 7(10):1425-1434 (1996).
Gospadarowicz, D., “Fibroblast growth factors: from genes to clinical applications,” Cell Biol. Rev., 25(4):307-314 (1991).
Hartung, et al., “Murine FGF-12 and FGF-13: expression in embryonic nervous system, connective tissue and heart,” Mech. Development, 64:31-39 (Jun. 1997).
Hoshikawa, et al., “Structure and expression of a novel fibroblast growth factor, FGF-17, preferentially expressed in the embryonic brain,” Biochem.Biophys. Res. Commun., 244:187-191 (1998).
Kirsch, et al., “Platelet-derived growth factor in human brain tumors,” J. Neuro Onco., 35(3):289-301 (1997).
Klagsbrun, et al., “The fibroblast growth factor family: structural and biological properties,” Progress in Growth Factor Research, 1:207-235 (1998).
Linnekin, et al., “Stem cell factor, the JAK-STAT pathway and signal transduction,” Leuk. Lymphoma 27(5-6):439-444 (1997).
Mason, I.J., “The ins and outs of fibroblast growth factors,” Cell, 78:547-552 (1994).
Payson, et al., “The human FGF-8 gene localizes on chromosome 10q24 and is subjected to inducation by androgen in breast cancer cells,” Oncogene 13(1):47-53 (1996).
Smallwood, et al., “Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development,” PNAS USA, 93:9850-9857 (1996).
Szebenyi, et al., “Fibroblast growth factors as multifunctional signaling factors,” Int. Rev. Cytol., 185:45-106 (1999).
Tanaka, et al., “Human androgen-induced growth factor in prostate and breast cancer cells: its molecular cloning and growth properties,” FEBS Letts., 363(3):226-230 (1995).
Tanaka, et al., “Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells,” PNAS USA, 89(19):8928-8932 (1992).
Vogel, et al., “Involvement of FGF-8 in initiation, outgrowth and patterning of the vertebrate limb,” Development, 122(6):1737-1750 (1996).
Terada. et al., “Heparin-binding growth factor genes,hst-1andhst2/FGF6,” Origins of Human Cancer: A review; Meeting, Cold Spring Harbor Laboratory Press: Plainview, New York, 404:675-683 (1991).
Vlodavsky, et al., “Sequestration and release of basic fibroblast growth factor,” Annals NY Acad. Sci., 1638:207-220 (1989).
Yao, et al., “Pretreatment with intravenous FGF-13 reduces infarct size and ameliorates neurological deficits following focal cerebral ischema in rats,” Soc. for Neuroscience Abstracts, 23(1-2):2439 (1997).
International Search Report for Application No. PCT/US00/40080 dated Dec. 28, 2000.
International Search Report for Application No. PCT/US97/20548 dated Apr. 21, 1998.
International Search Report for Application No. PCT/US95/07156 dated Sep. 11, 1995.
Supplementary European Search Report for Application No EP 95 92 2214 dated Mar. 31, 1998.
NCBI Accession NP—003858 “Fibroblast growth factor 17 precursor [Homo sapiens]”; PRI Dec. 20, 2003; REFSEQ: accession NM—003867.1.
Greene, et al., “Identification and characterization of a novel member of the fibroblast growth factor family,” European Jour. of Neurosci., vol. 10, pp. 1911-1925 (1998).
Miyamoto, et al., “Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property”, vol. 13, pp. 4251-4259 (Jul. 1993).
Greene John M.
Gruber Joachim R.
Rosen Craig A.
Human Genome Sciences Inc.
Human Genome Sciences Inc.
Romeo David
LandOfFree
Fibroblast growth factor-13 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibroblast growth factor-13, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibroblast growth factor-13 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3730988